GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OTCPK:CLPBY) » Definitions » Current Ratio

CLPBY (Coloplast AS) Current Ratio : 1.02 (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Coloplast AS Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Coloplast AS's current ratio for the quarter that ended in Sep. 2024 was 1.02.

Coloplast AS has a current ratio of 1.02. It generally indicates good short-term financial strength.

The historical rank and industry rank for Coloplast AS's Current Ratio or its related term are showing as below:

CLPBY' s Current Ratio Range Over the Past 10 Years
Min: 0.61   Med: 1.18   Max: 1.3
Current: 1.02

During the past 13 years, Coloplast AS's highest Current Ratio was 1.30. The lowest was 0.61. And the median was 1.18.

CLPBY's Current Ratio is ranked worse than
87.8% of 869 companies
in the Medical Devices & Instruments industry
Industry Median: 2.6 vs CLPBY: 1.02

Coloplast AS Current Ratio Historical Data

The historical data trend for Coloplast AS's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Current Ratio Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.30 1.11 1.20 0.61 1.02

Coloplast AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.61 0.53 0.60 0.85 1.02

Competitive Comparison of Coloplast AS's Current Ratio

For the Medical Instruments & Supplies subindustry, Coloplast AS's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Current Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Current Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Current Ratio falls into.



Coloplast AS Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Coloplast AS's Current Ratio for the fiscal year that ended in Sep. 2024 is calculated as

Current Ratio (A: Sep. 2024 )=Total Current Assets (A: Sep. 2024 )/Total Current Liabilities (A: Sep. 2024 )
=1554.629/1518.904
=1.02

Coloplast AS's Current Ratio for the quarter that ended in Sep. 2024 is calculated as

Current Ratio (Q: Sep. 2024 )=Total Current Assets (Q: Sep. 2024 )/Total Current Liabilities (Q: Sep. 2024 )
=1554.629/1518.904
=1.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Coloplast AS  (OTCPK:CLPBY) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Coloplast AS Current Ratio Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

From GuruFocus

Q1 2022 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2022 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Coloplast A/S Virtual ESG Event Call Transcript

By GuruFocus Research 02-13-2024

Q1 2021 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2023 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2023 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Coloplast A/S to Acquire Atos Medical Call Transcript

By GuruFocus Research 02-13-2024

Coloplast A/S Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Q1 2023 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024